☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Coherus Biosciences
Coherus BioSciences to Acquire Surface Oncology for ~$65M
June 19, 2023
Coherus BioSciences Reports the Pooled Analysis of Udenyca (biosimilar, pegfilgrastim) Demonstrated Similar Immunogenicity to Neul...
February 1, 2022
Top Biosimilar Companies with Approved and Pipeline Products in the US and EU
November 29, 2019
Insights+ Key Biosimilars Events of July 2019
August 10, 2019
Load more...
Back to Home
